CFDE Data Portal | Search LINC02101

	Label	Description
	LINC02101 Gene (Entity type)	ENSG00000248132 - long intergenic non-protein coding RNA 2101
	GSE203329 HCC knockout 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209698 calcitriol D 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 gemcitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 gemcitabine 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Spleen 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE252944 AKT inhibition 11 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02101

ENSG00000248132 - long intergenic non-protein coding RNA 2101

GSE203329 HCC knockout 2 v 1 human up

A Gene Set from LINCS

GSE236502 paclitaxel 1 v 3 human up

A Gene Set from LINCS

GSE209698 calcitriol D 2 v 1 human up

A Gene Set from LINCS

GSE218060 decitabine T cell 2 v 4 human up

A Gene Set from LINCS

GSE148200 gemcitabine 1 v 2 human up

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 0 v 6 human up

A Gene Set from LINCS

GSE148200 gemcitabine 1 v 5 human up

A Gene Set from LINCS

GTEx Spleen 20-29 vs 60-69 Up

A Gene Set from GTEx

GSE252944 AKT inhibition 11 v 13 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.